In the current issue of the journal four papers are dedicated to the treatment, and the related toxicity, of conditions caused by the deposition of monoclonal light chains, including AL amyloidosis and light chain cast nephropathy. In particular, the paper by Kastritis et al .[1][1] reports, for the
No takes yet. Share an insight, caveat, or question.
Sitia et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: